U.S. flag

An official website of the United States government

NM_000251.3(MSH2):c.67T>C (p.Phe23Leu) AND not specified

Germline classification:
Benign (1 submission)
Last evaluated:
Jul 9, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000417652.5

Allele description [Variation Report for NM_000251.3(MSH2):c.67T>C (p.Phe23Leu)]

NM_000251.3(MSH2):c.67T>C (p.Phe23Leu)

Gene:
MSH2:mutS homolog 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p21
Genomic location:
Preferred name:
NM_000251.3(MSH2):c.67T>C (p.Phe23Leu)
HGVS:
  • NC_000002.12:g.47403258T>C
  • NG_007110.2:g.5135T>C
  • NM_000251.3:c.67T>CMANE SELECT
  • NM_001258281.1:c.-31+83T>C
  • NP_000242.1:p.Phe23Leu
  • NP_000242.1:p.Phe23Leu
  • LRG_218t1:c.67T>C
  • LRG_218:g.5135T>C
  • LRG_218p1:p.Phe23Leu
  • NC_000002.11:g.47630397T>C
  • NM_000251.1:c.67T>C
  • NM_000251.2:c.67T>C
Protein change:
F23L
Links:
dbSNP: rs372619120
NCBI 1000 Genomes Browser:
rs372619120
Molecular consequence:
  • NM_001258281.1:c.-31+83T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000251.3:c.67T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000919711Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Benign
(Jul 9, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

Shi E, Chmielecki J, Tang CM, Wang K, Heinrich MC, Kang G, Corless CL, Hong D, Fero KE, Murphy JD, Fanta PT, Ali SM, De Siena M, Burgoyne AM, Movva S, Madlensky L, Heestand GM, Trent JC, Kurzrock R, Morosini D, Ross JS, Harismendy O, et al.

J Transl Med. 2016 Dec 14;14(1):339.

PubMed [citation]
PMID:
27974047
PMCID:
PMC5157084

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000919711.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: MSH2 c.67T>C (p.Phe23Leu) results in a non-conservative amino acid change located in the DNA mismatch repair protein MutS-like, N-terminal domain of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00057 in 246202 control chromosomes, predominantly within the South Asian subpopulation in the gnomAD database at a frequency of 0.0049, including 2 homozygotes. This frequency within South Asian control individuals is approximately 9-fold above the estimated maximal expected allele frequency for a pathogenic variant in MSH2 causing Lynch Syndrome phenotype (0.00057), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. The variant has been reported in a patient with gastrointestinal stromal cancer, but without evidence of causality. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024